Search alternatives:
points increased » point increase (Expand Search), costs increased (Expand Search), contents increased (Expand Search)
marked decrease » marked increase (Expand Search)
a marked » a marker (Expand Search), _ marked (Expand Search), a market (Expand Search)
points increased » point increase (Expand Search), costs increased (Expand Search), contents increased (Expand Search)
marked decrease » marked increase (Expand Search)
a marked » a marker (Expand Search), _ marked (Expand Search), a market (Expand Search)
-
1
The Laboratory Animal Flow Diagram.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
2
<sup>1</sup>H NMR spectra for kylo-0603.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
3
<sup>13</sup>C NMR spectra for Kylo-0603.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
4
The structures of T3 and Kylo-0603.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
5
Synthesis process of Kylo-0603.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
6
ESI-HRMS spectra for Kylo-0603.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Customized Surface Design to Increase Throughput of Ambient Ionization Mass Spectrometry Lipidomics
Published 2023Subjects: -
15
Customized Surface Design to Increase Throughput of Ambient Ionization Mass Spectrometry Lipidomics
Published 2023Subjects: -
16
Customized Surface Design to Increase Throughput of Ambient Ionization Mass Spectrometry Lipidomics
Published 2023Subjects: -
17
Customized Surface Design to Increase Throughput of Ambient Ionization Mass Spectrometry Lipidomics
Published 2023Subjects: -
18
Customized Surface Design to Increase Throughput of Ambient Ionization Mass Spectrometry Lipidomics
Published 2023Subjects: -
19
-
20